Documents
-
REGISTRATION STATEMENT
S-4
-
CERO THERAPEUTICS, INC. 2016 EQUITY INCENTIVE PLAN, AS AMENDED, AND FORMS OF AWARD AGREEMENTS THEREUNDER
EX-10.1
-
FORM OF CONVERTIBLE NOTE PURCHASE AGREEMENT, BY AND AMONG CERO THERAPEUTICS, INC. AND THE PURCHASERS SIGNATORY THERETO, DATED MAY [ ], 2023
EX-10.19
-
CONSENT OF WOLF & CO., INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-23.1
-
CONSENT OF CITRIN COOPERMAN & COMPANY LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.
EX-23.3
-
CONSENT OF DANIEL COREY TO BE NAMED AS A DIRECTOR
EX-99.1
-
FILING FEE TABLE
EX-FILING FEES
-
XBRL SCHEMA FILE
EX-101.SCH
-
XBRL CALCULATION FILE
EX-101.CAL
-
XBRL DEFINITION FILE
EX-101.DEF
-
XBRL LABEL FILE
EX-101.LAB
-
XBRL PRESENTATION FILE
EX-101.PRE
On sec.gov